Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
MyHealthChecked (LON: MHC) shares are rallying Wednesday after the company said it is launching 2 home testing services for travellers entering and departing the UK.
The online service will allow customers to order a test before arriving in England or departing from the UK.
Starting today, the company will begin selling a rapid antigen test and a verification service for residents and vaccinated travellers arriving in England from a non-red list country, followed by a Fit to Fly rapid test for travellers leaving the UK launching next week.
In addition, MyHealthChecked has partnered with Mediskills, who will provide fully trained NHS professionals to verify test results.
Penny McCormick, CEO of MyHealthChecked, said: “Our focus on ensuring the best possible customer service has already allowed us to meet the needs of our key retail partners and has established a trusted relationship based on the best possible service delivery.”
MyHealthChecked shares are currently up 12.2% at 2.3p.
MyHealthChecked shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are MHC shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .